Disposition of 514 shares by Spencer Stiles of Stryker at 1.16 subject to Rule 16b-3
SHPCX Fund | USD 13.90 0.03 0.22% |
Slightly above 55% of Health Biotchnology's investor base is interested to short. The analysis of overall sentiment of trading Health Biotchnology Portfolio mutual fund suggests that many investors are impartial at this time. Health Biotchnology's investing sentiment can be driven by a variety of factors including economic data, Health Biotchnology's earnings reports, geopolitical events, and overall market trends.
Health |
Filed transaction by Stryker Officer: Group President. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at massdevice.com
Health Biotchnology Fundamental Analysis
We analyze Health Biotchnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health Biotchnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health Biotchnology based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Health Biotchnology is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Health Biotchnology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Health Biotchnology mutual fund to make a market-neutral strategy. Peer analysis of Health Biotchnology could also be used in its relative valuation, which is a method of valuing Health Biotchnology by comparing valuation metrics with similar companies.
Peers
Health Biotchnology Related Equities
VOLMX | Volumetric Fund | 0.34 | ||||
TQAAX | T Rowe | 0.32 | ||||
CPUCX | Aam Select | 0.32 | ||||
WRLDX | Scharf Global | 0.24 | ||||
ABVCX | Ab Value | 0.1 | ||||
TWBIX | Balanced Fund | 0.1 |
Other Information on Investing in Health Mutual Fund
Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |